Mesoblast’s RYONCIL ® (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA approved mesenchymal ...
It’s not HBO, it’s Max — but the new logo for Warner Bros. Discovery’s streamer now certainly looks like HBO’s at a glance.
Holzbrecher-Morys from the German Hospital Federation explains what the hospital reform means for hospitals in terms of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results